Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.1(PAH):c.782G>A (p.Arg261Gln)

CA251528

582 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 9e4b6d0e-936a-4cbe-a237-e66213b685d4

HGVS expressions

NM_000277.1:c.782G>A

NM_000277.1(PAH):c.782G>A (p.Arg261Gln)

NC_000012.12:g.102852875C>T

CM000674.2:g.102852875C>T

NC_000012.11:g.103246653C>T

CM000674.1:g.103246653C>T

NC_000012.10:g.101770783C>T

NG_008690.1:g.69728G>A

NG_008690.2:g.110536G>A

NM_000277.2:c.782G>A

NM_001354304.1:c.782G>A

NM_000277.3:c.782G>A

ENST00000307000.7:c.767G>A

ENST00000549247.6:n.541G>A

ENST00000553106.5:c.782G>A

Pathogenic

PM3_Very Strong PS3 PP3 PP4_Moderate

PM2

Evidence Links 3

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

PAH-specific ACMG/AMP criteria applied: PP3: tools predict damaging; PS3: 15.5-30% activity (PMID:2014036; PMID:25596310); PM3_VeryStrong: L48S, R408W, S349P, R243X (PMID:25596310; PMID:17935162); PP4_Moderate: (PMID:25596310). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP3, PS3, PM3_VeryStrong, PP4_Moderate).

PM3_Very Strong

L48S, R408W, S349P, R243X

Table 2_Residual PAH activity and optimal enzymatic working range of PAH proteins_R261Q in trans with L48S or R408W known PATH var; or R261 homo pt also seen in this table with increased Phe level, reduced residual enzyme activity. PubMed:25596310

The BIOPKUdb comprises genotypes information from 315 BH4-responsive patients. Patient genotypes mentioned: p.R261Q/ p.L48S, p.R261Q/p.R53H (VarID 102601, VUS/LB); p.R261Q/ p.S349P (VarID 615 P/LP), p.R261Q/p.R243X (VarID 588, P). PubMed:17935162

PS3

15.5-30% activity

PAH enzyme activity of a patients with phenylketonuria was 15.5% activity of WT (Table S4). This paper also reports a high number of homozygous and compound heterozygous patients PubMed:25596310

R261Q mutant PAH activity measurement resulted in a 30% of the WT activity (Table 1) PubMed:2014036

PP3

No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline

PP4_Moderate

PM2

gnomAD MAF 0.00039

Approved on: 2018-08-13

Published on: 2019-04-05

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.